Documented Asbestos Litigation

According to publicly filed asbestos litigation records (reviewed via CourtListener/RECAP), Pharmacia has been named as a defendant in 400+ documented asbestos dockets filed between 2001 and 2026 — concentrated in the federal asbestos multidistrict litigation (In re: Asbestos Products Liability Litigation, MDL 875, E.D. Pennsylvania) and other U.S. district courts. In these cases Pharmacia is named not as a manufacturer of asbestos products but in a premises/contractor capacity: Chemical-plant premises owner (Pharmacia Corp. is the renamed former Monsanto Company) sued for asbestos-insulation exposure by contractor employees at its chemical plants, not as a products maker.. Plaintiffs allege exposure to asbestos-containing materials at its facilities, or that it installed or distributed asbestos products made by other companies.

Companies Frequently Named Alongside Pharmacia

In these publicly filed cases, Pharmacia is most often named as a co-defendant alongside General Electric, CBS, FMC, Honeywell International, Union Carbide, Gardner Denver, ITT, Ingersoll-Rand — reflecting the multi-defendant nature of asbestos litigation, in which plaintiffs name the range of companies connected to their exposure history.

Occupational Exposure and Asbestos Disease

Asbestos exposure is associated with mesothelioma, asbestosis, and asbestos-related lung cancer, typically after a latency period of two to five decades. Workers in industrial trades — maintenance, construction, shipyard, power generation, and manufacturing — are among those most frequently represented in asbestos litigation.

The litigation record above reflects allegations from publicly filed asbestos cases; these are plaintiff allegations, not findings of fact, and liability is determined case by case. An attorney experienced in asbestos litigation can evaluate whether a specific work and exposure history supports a claim involving Pharmacia.